{"DataElement":{"publicId":"64731","version":"4","preferredName":"Tumor Marker Test Type","preferredDefinition":"the test name or method used to assess a specific marker that indicates presence of cancer or tumor.","longName":"TMMKR_TST_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2014604","version":"1","preferredName":"Tumor Marker Test","preferredDefinition":"a test for a biological marker which indicates the presence or status of tumor in a patient.","longName":"TMMKR_TST","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2176932","version":"1","preferredName":"Tumor Marker","preferredDefinition":"A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.","longName":"Tumor Marker","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7B02-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177310","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"Test","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-52C4-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Added Concept Code AA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9E099F6-CDC1-4D8E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-27","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015522","version":"3","preferredName":"Tumor Marker Test Type","preferredDefinition":"a test name or method used to assess a specific marker that indicates presence of cancer or tumor.","longName":"TMMKR_TST_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"45","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ELISA","valueDescription":"ELISA","ValueMeaning":{"publicId":"2558713","version":"1","preferredName":"ELISA","longName":"2558713","preferredDefinition":"ELISA","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ELISA","conceptCode":"C16553","definition":"A highly sensitive technique for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attached, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. (BioTech Life Science Dictionary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B266-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9F1F017-8BDD-13F7-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Fluorescence in situ hybridization (FISH)","valueDescription":"FLUORESCENCE IN SITU HYBRIDIZATION (FISH)","ValueMeaning":{"publicId":"2558796","version":"1","preferredName":"FLUORESCENCE IN SITU HYBRIDIZATION (FISH)","longName":"2558796","preferredDefinition":"FLUORESCENCE IN SITU HYBRIDIZATION (FISH)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B2B9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9F1F017-8BDF-13F7-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Immunohistochemistry (IHC)","valueDescription":"IMMUNOHISTOCHEMISTRY (IHC)","ValueMeaning":{"publicId":"2558927","version":"1","preferredName":"IMMUNOHISTOCHEMISTRY (IHC)","longName":"2558927","preferredDefinition":"IMMUNOHISTOCHEMISTRY (IHC)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B33C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9F1F017-8BE1-13F7-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other specify","ValueMeaning":{"publicId":"2570538","version":"1","preferredName":"Other specify","longName":"2570538","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12 - reversed concept order to match the semantics of this phrase which is \"other\" with \"specify\" as a qualifier/modifier - DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9F1F017-8BE3-13F7-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-28","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Serum ECD test","valueDescription":"Serum extracellular domain (ECD) test","ValueMeaning":{"publicId":"2574562","version":"1","preferredName":"Serum extracellular domain (ECD) test","longName":"2574562","preferredDefinition":"Serum extracellular domain (ECD) test","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F04F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-04-25","modifiedBy":"CAMPBELB","dateModified":"2005-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F59807C3-6706-3E1E-E034-0003BA3F9857","beginDate":"2005-04-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-04-25","modifiedBy":"ONEDATA","dateModified":"2005-04-25","deletedIndicator":"No"},{"value":"RT-PCR","valueDescription":"RTPCR, RT-PCR,  reverse transcriptase-polymerase chain reaction ","ValueMeaning":{"publicId":"2565772","version":"1","preferredName":"RTPCR, RT-PCR,  reverse transcriptase-polymerase chain reaction ","longName":"2565772","preferredDefinition":"A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDF9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-03-04","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-04","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24E45B7C-BE16-491C-E044-0003BA3F9857","beginDate":"2006-12-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-12-18","modifiedBy":"CAMPBELB","dateModified":"2006-12-18","deletedIndicator":"No"},{"value":"Ligand Binding Assay","valueDescription":"Ligand binding assay","ValueMeaning":{"publicId":"2582516","version":"1","preferredName":"Ligand binding assay","longName":"2582516","preferredDefinition":"Ligand binding assay","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0F61-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-12-18","modifiedBy":"CAMPBELB","dateModified":"2006-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24E46436-1E4E-3722-E044-0003BA3F9857","beginDate":"2006-12-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-12-18","modifiedBy":"ONEDATA","dateModified":"2006-12-18","deletedIndicator":"No"},{"value":"PCR","valueDescription":"PCR, Polymerase Chain Reaction","ValueMeaning":{"publicId":"2565773","version":"1","preferredName":"PCR, Polymerase Chain Reaction","longName":"2565773","preferredDefinition":"polymerase chain reaction (PCR). an enzymatic method for the repeated copying and amplification of the two strands of DNA of a particular gene sequence. (from STED98)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDFA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-03-04","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-04","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5790DF03-1578-2F13-E044-0003BA3F9857","beginDate":"2008-09-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-09-23","modifiedBy":"ONEDATA","dateModified":"2008-09-23","deletedIndicator":"No"},{"value":"in situ Hybridization","valueDescription":"in situ Hybridization","ValueMeaning":{"publicId":"2939763","version":"1","preferredName":"in situ Hybridization","longName":"2939763","preferredDefinition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Situ Hybridization","conceptCode":"C17562","definition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73532DB0-AF1C-0CB6-E040-BB89AD432D0F","latestVersionIndicator":"Yes","beginDate":"2009-09-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73532DB0-AF35-0CB6-E040-BB89AD432D0F","beginDate":"2009-09-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-11","modifiedBy":"ONEDATA","dateModified":"2009-09-11","deletedIndicator":"No"},{"value":"Microarray","valueDescription":"Microarray","ValueMeaning":{"publicId":"2575508","version":"1","preferredName":"Microarray","longName":"2575508","preferredDefinition":"A microarray is a piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microarray","conceptCode":"C44282","definition":"A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F401-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-06","endDate":null,"createdBy":"HARDINGR","dateCreated":"2005-07-06","modifiedBy":"CURTIST","dateModified":"2009-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73532DB0-AF49-0CB6-E040-BB89AD432D0F","beginDate":"2009-09-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-11","modifiedBy":"ONEDATA","dateModified":"2009-09-11","deletedIndicator":"No"},{"value":"CGH","valueDescription":"Comparative Genomic Hybridization","ValueMeaning":{"publicId":"3082342","version":"1","preferredName":"Comparative Genomic Hybridization","longName":"3082342","preferredDefinition":"Comparative genomic hybridization (CGH) is a technique that allows the detection of losses and gains in DNA copy number across the entire genome without prior knowledge of specific chromosomal abnormalities.  Comparative genomic hybridization utilizes the hybridization of differentially labeled tumor and reference DNA to generate a map of DNA copy number changes in tumor genomes. Comparative genomic hybridization is an ideal tool for analyzing chromosomal imbalances in archived tumor material and for examining possible correlations between these findings and tumor phenotypes. (from Ried et al. J Mol Med 1997 75:801-14)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comparative Genomic Hybridization","conceptCode":"C18084","definition":"Comparative genomic hybridization (CGH) is a technique that allows the detection of losses and gains in DNA copy number across the entire genome without prior knowledge of specific chromosomal abnormalities.  Comparative genomic hybridization utilizes the hybridization of differentially labeled tumor and reference DNA to generate a map of DNA copy number changes in tumor genomes. Comparative genomic hybridization is an ideal tool for analyzing chromosomal imbalances in archived tumor material and for examining possible correlations between these findings and tumor phenotypes. (from Ried et al. J Mol Med 1997 75:801-14)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85ED90AF-5DF6-DB39-E040-BB89AD434039","latestVersionIndicator":"Yes","beginDate":"2010-05-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85ED90AF-5E0F-DB39-E040-BB89AD434039","beginDate":"2010-05-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-05-06","modifiedBy":"ONEDATA","dateModified":"2010-05-06","deletedIndicator":"No"},{"value":"LOH","valueDescription":"Loss of Heterozygosity","ValueMeaning":{"publicId":"3082343","version":"1","preferredName":"Loss of Heterozygosity","longName":"3082343","preferredDefinition":"genetic phenomenon due to deletion or mutation in one allele of a polymorphic gene, as detected by expression after cell fusion; used as a test for tumor-promoting mutations; do not confuse with \"loss of heterogeneity\" which applies to diverse cell populations within a tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Heterozygosity","conceptCode":"C18016","definition":"A genetic variation where gain, loss, or exchange of DNA results in monoallelic loss of function mutations in a diploid cell. In the context of tumor suppressor genes, where a single copy is sufficient for functionality, loss of function for the second allele is associated with tumorigenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85ED90AF-5E19-DB39-E040-BB89AD434039","latestVersionIndicator":"Yes","beginDate":"2010-05-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85ED90AF-5E32-DB39-E040-BB89AD434039","beginDate":"2010-05-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-05-06","modifiedBy":"ONEDATA","dateModified":"2010-05-06","deletedIndicator":"No"},{"value":"Unspecified","valueDescription":"Unspecified","ValueMeaning":{"publicId":"2573360","version":"1","preferredName":"Unspecified","longName":"2573360","preferredDefinition":"Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EB9D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"KLINGERK","dateCreated":"2005-03-06","modifiedBy":"TSESU","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2DA5-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"Mass Spectrometry","valueDescription":"Mass Spectrometry","ValueMeaning":{"publicId":"3339145","version":"1","preferredName":"Mass Spectrometry","longName":"3339145","preferredDefinition":"An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mass Spectrometry","conceptCode":"C17156","definition":"An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CBC6F0-09E2-06B9-E040-BB89AD434070","latestVersionIndicator":"Yes","beginDate":"2011-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2DB9-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"Cytotoxicity Assay","valueDescription":"Cytotoxicity Assay","ValueMeaning":{"publicId":"3645809","version":"1","preferredName":"Cytotoxicity Assay","longName":"3645809","preferredDefinition":"The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells.  In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed.: The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxicity","conceptCode":"C27988","definition":"The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells.  In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assay","conceptCode":"C60819","definition":"A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110A16D-2DC7-9201-E040-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2DE0-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"Proliferation Assay","valueDescription":"Proliferation Marker Assay","ValueMeaning":{"publicId":"3645811","version":"1","preferredName":"Proliferation Marker Assay","longName":"3645811","preferredDefinition":"Refers to specific proteins or other factors in actively growing and dividing cells, whose presence serves as an indicator for such cells.  For instance, proliferating cell nuclear antigen (PCNA) or mitotic index.: The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proliferation Marker","conceptCode":"C18395","definition":"Refers to specific proteins or other factors in actively growing and dividing cells, whose presence serves as an indicator for such cells.  For instance, proliferating cell nuclear antigen (PCNA) or mitotic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assay","conceptCode":"C60819","definition":"A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110A16D-2DEE-9201-E040-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2E07-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"ELISPOT","valueDescription":"Enzyme-linked Immunosorbent Spot Assay","ValueMeaning":{"publicId":"3645813","version":"1","preferredName":"Enzyme-linked Immunosorbent Spot Assay","longName":"3645813","preferredDefinition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enzyme-linked Immunosorbent Spot Assay","conceptCode":"C102632","definition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110A16D-2E14-9201-E040-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2E2D-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"Sequencing","valueDescription":"Nucleic Acid Sequencing","ValueMeaning":{"publicId":"3339147","version":"1","preferredName":"Nucleic Acid Sequencing","longName":"3339147","preferredDefinition":"The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nucleic Acid Sequencing","conceptCode":"C18881","definition":"The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CBC6F0-0A13-06B9-E040-BB89AD434070","latestVersionIndicator":"Yes","beginDate":"2011-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2E37-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"Flow Cytometry","valueDescription":"Flow Cytometry","ValueMeaning":{"publicId":"2974014","version":"1","preferredName":"Flow Cytometry","longName":"2974014","preferredDefinition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flow Cytometry","conceptCode":"C16585","definition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10AD-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2E42-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"Western Blot (Immunoblot)","valueDescription":"Blotting, Western","ValueMeaning":{"publicId":"3173903","version":"1","preferredName":"Blotting, Western","longName":"3173903","preferredDefinition":"Identification of proteins or peptides that have been separated by gel electrophoresis and transferred (blotted) to strips of nitrocellulose paper. The blots are then detected by enzymatically labelled or radiolabeled antibody probes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Western Blotting","conceptCode":"C16357","definition":"A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EFE7BF-3643-DFE9-E040-BB89AD4369C7","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-12-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D110A16D-2E56-9201-E040-BB89AD436122","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"ONEDATA","dateModified":"2012-12-17","deletedIndicator":"No"},{"value":"Protein Activity Assay","valueDescription":"Protein or Enzyme Activity","ValueMeaning":{"publicId":"3613683","version":"1","preferredName":"Protein or Enzyme Activity","longName":"3613683","preferredDefinition":"A term that refers to a chemistry test measuring a specific protein or enzyme in the peripheral blood or body fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein or Enzyme Type Measurement","conceptCode":"C64430","definition":"A term that refers to a chemistry test measuring a specific protein or enzyme in the peripheral blood or body fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1F23BD-298A-2478-E040-BB89AD430CEE","latestVersionIndicator":"Yes","beginDate":"2012-10-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5B520BD-B310-8731-E040-BB89AD431A7E","beginDate":"2013-02-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-14","modifiedBy":"ONEDATA","dateModified":"2013-02-14","deletedIndicator":"No"},{"value":"Microscopy/Imaging","valueDescription":"Microscopy Imaging Technique","ValueMeaning":{"publicId":"3684468","version":"1","preferredName":"Microscopy Imaging Technique","longName":"3684468","preferredDefinition":"The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye.: Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopy","conceptCode":"C16853","definition":"The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D577786F-7B19-468E-E040-BB89AD430AE8","latestVersionIndicator":"Yes","beginDate":"2013-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5B520BD-B325-8731-E040-BB89AD431A7E","beginDate":"2013-02-14","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-14","modifiedBy":"ONEDATA","dateModified":"2013-02-14","deletedIndicator":"No"},{"value":"DAKO Herceptest","valueDescription":"Herceptest","ValueMeaning":{"publicId":"3718571","version":"1","preferredName":"Herceptest","longName":"3718571","preferredDefinition":"Test for identification of breast cancer patients with tumors that produce excessive amounts of the HER-2 protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HercepTest","conceptCode":"C25524","definition":"An FDA approved test for the evaluation of HER2 protein overexpression in breast tumors.  It provides semi-quantitative results of p185HER2 (HER2 gene) overexpression in Bouin or formalin-fixed, routinely processed, paraffin-embedded breast cancer tissues by light microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9D937BB-3A1B-8771-E040-BB89AD432B06","latestVersionIndicator":"Yes","beginDate":"2013-04-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9D937BB-3A34-8771-E040-BB89AD432B06","beginDate":"2013-04-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-04-08","modifiedBy":"ONEDATA","dateModified":"2013-04-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9F1F017-8BDA-13F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-28","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-28","modifiedBy":"PWEST","dateModified":"2014-05-15","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"},{"publicId":"2811964","version":"1","longName":"Tumor Markers","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811932","version":"1","longName":"Pathology Breast","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"},{"publicId":"3248617","version":"1","longName":"CCR 2011 Template","context":"CCR"},{"publicId":"3248635","version":"1","longName":"Pathology Report","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811716","version":"1","longName":"UC Irvine","context":"NCIP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812624","version":"1","longName":"Breast Cancer Data Mart","context":"CTEP"}]},{"publicId":"2939361","version":"1","longName":"DCTD (Division of Cancer Treatment and Diagnosis)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2939362","version":"1","longName":"Clinical Assay Development","context":"NCIP"},{"publicId":"3263369","version":"1","longName":"Biomarker Abstraction","context":"NCIP"}]}],"AlternateNames":[{"name":"TMMKR_TST_TP","type":"C3D Name","context":"CTEP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"AECC","type":"USED_BY","context":"AECC"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Tumor Marker Test Method","url":null,"context":"CTEP"},{"name":"Marker Test Method","type":"Preferred Question Text","description":"Marker Test Method","url":null,"context":"CTEP"},{"name":"Type of assay","type":"Alternate Question Text","description":"Type of assay","url":null,"context":"NCIP"},{"name":"AECC Text","type":"Alternate Question Text","description":"Specific Assay","url":null,"context":"AECC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B9F1C96C-F3FE-1212-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-28","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-28","modifiedBy":"DWARZEL","dateModified":"2020-07-27","changeDescription":"updated for ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}